| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4274dccc5817d8d1b6e1dece0a02636b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f7b1069d79103fdedf8e0fe872d3f6d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0026d2364d16adf52217a54555b48768 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 |
| filingDate |
2020-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f12ad22cbffdbbc5360562f330e3e45d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7960415898c23204a32064463c71a824
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2fe6c8c8dfd61092121e900735e68735 |
| publicationDate |
2022-04-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220042129-A |
| titleOfInvention |
Novel theta defensin analogs |
| abstract |
Novel peptide analogs of [theta]-defensins have been developed that provide a biphasic effect in treating infection and/or sepsis. These analogs have activity even at concentrations lower than those necessary to provide a bactericidal or bacteriostatic effect, and initially summon effector cells of the immune system to resolve infectious organisms and then modulate the immune system, thereby reducing the risk of sepsis and septic shock. down-regulates the features of the inflammatory response; These novel [theta]-defensin analogs are protective even at concentrations where naturally occurring [theta]-defensins have no apparent effect, and contain a key set of structural and sequence properties not found in native [theta]-defensins. |
| priorityDate |
2019-06-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |